EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

iFIND INH/FQ: a LC-aNAAT assay for rapid simultaneous detection of isoniazid and fluoroquinolone resistance in Mycobacterium tuberculosis

Xichao Ou, Yingzi Ma, Huiwen Zheng iD, Yan Li, Jiaojian Zeng, Yuying Chen, Lin Huang, Yajie Guo, Bing Zhao, Jingjing Li, Ruida Xing, Hui Xia iD und 1 weitere

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.03743-25 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Xichao Ou und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chi…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Fluoroquinolones, Isoniazid, Antitubercular Agents. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate the performance of the iFIND INH/FQ, a low-complexity molecular assay, for the rapid and simultaneous detection of resistance to isoniazid (INH) and fluoroquinolones (FQs) in Mycobacterium tuberculosis . Frozen sputum specimens stored at the Chengde Center for Disease Control and Prevention laboratory were used. Phenotypic drug susceptibility testing (pDST) and DNA sequencing served as reference standards. The limit of detection (LOD) was determined using probit regression with spiked samples. The assay’s ability to detect resistance-conferring mutations in katG , inhA , and gyrA genes was assessed using genotypically characterized strains. Diagnostic accuracy was evaluated against pDST. The LOD was 20.79 CFU/mL for INH and 9.34 CFU/mL for FQs. The assay detected all targeted mutations except ahpC c.-6 associated with INH resistance. Compared to pDST, the iFIND INH/FQ assay demonstrated a sensitivity of 97.59% (95% confidence interval [CI]: 91.63–99.34%) and specificity of 98.10% (95% CI: 94.57–99.35%) for INH resistance. For FQ resistance, sensitivity was 92.16% (95% CI: 81.50–96.91%) for levofloxacin and 92.00% (95% CI: 81.16–96.85%) for moxifloxacin, with specificities of 97.33% (95% CI: 93.89–98.85%) and 96.81% (95% CI: 93.21–98.53%), respectively. Sequencing confirmed iFIND results in the majority of discrepant cases (100% for INH and 55.65% for FQs). The iFIND INH/FQ LC-aNAAT is a highly accurate and rapid molecular assay for simultaneous detection of INH and FQ resistance. It is a promising tool for scaling up rapid drug susceptibility testing in clinical and peripheral laboratory settings. IMPORTANCE As a low-complexity automated nucleic acid amplification test, the iFIND assay achieves the goal of simultaneously detecting isoniazid and fluoroquinolone resistance in approximately 90 min, perfectly meeting the TPP's core requirements for “rapid” and “simple operation.” Its fully integrated system minimizes manual steps and contamination risk, making it highly suitable for use in resource-limited, lower-biosafety-level primary laboratories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisFluoroquinolonesIsoniazidAntitubercular AgentsTuberculosis, Multidrug-ResistantDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsSensitivity and SpecificityBacterial ProteinsDNA GyraseDrug Resistance, BacterialMutationOxidoreductasesCatalaseSputum

Stichwörter der Autor:innen

Mycobacterium tuberculosisdrug resistancefluoroquinolonesisoniazidmolecular diagnostics

Substanzen

FluoroquinolonesIsoniazidAntitubercular AgentsBacterial ProteinsDNA GyraseOxidoreductasesCatalase

Autor:innen und Institutionen

  • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention (Chinese Academy of Pre…
  • Tuberculosis Prevention and Control Division, Chengde Center for Disease Control and Prevention (Chengde Health Inspection Institute), Chengde, China.
  • Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, Laboratory of Respirat…

ORCID-Profile: Huiwen Zheng, Hui Xia, Yanlin Zhao

Zitieren

APA

Ou, X., Ma, Y., Zheng, H., Li, Y., Zeng, J., Chen, Y., Huang, L., Guo, Y., Zhao, B., Li, J., Xing, R., Xia, H., & Zhao, Y. (2026). iFIND INH/FQ: a LC-aNAAT assay for rapid simultaneous detection of isoniazid and fluoroquinolone resistance in Mycobacterium tuberculosis. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03743-25

Vancouver

Ou X, Ma Y, Zheng H, Li Y, Zeng J, Chen Y, et al. iFIND INH/FQ: a LC-aNAAT assay for rapid simultaneous detection of isoniazid and fluoroquinolone resistance in Mycobacterium tuberculosis. Microbiology Spectrum. 2026. doi:10.1128/spectrum.03743-25

BibTeX
@article{Ou2026,
  author = {Ou, Xichao and Ma, Yingzi and Zheng, Huiwen and Li, Yan and Zeng, Jiaojian and Chen, Yuying and Huang, Lin and Guo, Yajie and Zhao, Bing and Li, Jingjing and Xing, Ruida and Xia, Hui and Zhao, Yanlin},
  title = {iFIND INH/FQ: a LC-aNAAT assay for rapid simultaneous detection of isoniazid and fluoroquinolone resistance in Mycobacterium tuberculosis},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.03743-25}
}
Kostenlos starten →